Literature DB >> 33411171

Brucellosis screening and follow-up of seropositive asymptomatic subjects among household members of shepherds in China.

Jing Hu1, Xiangyi Zhang1, Huixin Yang1, Siwen Zhang1, Taijun Wang1, Shuqi An1, Mujinyan Li1, Fande Li1, Jingjing Luo1, Fangfang Hu1, Dali Wang2, Shaonan Ni1, Jian Sheng1, Cui Zhang1, Qing Zhen3.   

Abstract

To measure the seroprevalence of high-exposure populations in brucellosis endemic areas and report the outcome and duration of seropositive asymptomatic subjects, we screened 595 family members of shepherds in Jilin Province, China and then followed up 15 seropositive asymptomatic subjects for 18 months. We found that the seropositive rate of 15.5%. Nearly half of seropositive asymptomatic subjects (7/15) developed into brucellosis in the short term; others were still seropositive asymptomatic or had decreased SAT titer in a longer time.

Entities:  

Keywords:  follow-up; seropositive asymptomatic; shepherds

Year:  2021        PMID: 33411171     DOI: 10.1007/s10096-020-04115-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

1.  The effects of environmental conditions on persistence and inactivation of Brucella suis on building material surfaces.

Authors:  M Worth Calfee; M Wendling
Journal:  Lett Appl Microbiol       Date:  2012-03-29       Impact factor: 2.858

2.  Utility of an immunocapture-agglutination test and an enzyme-linked immunosorbent assay test against cytosolic proteins from Brucella melitensis B115 in the diagnosis and follow-up of human acute brucellosis.

Authors:  María Angeles Mantecón; Purificación Gutiérrez; María del Pilar Zarzosa; Ana I Dueñas; Javier Solera; Luis Fernández-Lago; Nieves Vizcaíno; Ana Almaraz; Miguel Angel Bratos; Antonio Rodríguez Torres; Antonio Orduña-Domingo
Journal:  Diagn Microbiol Infect Dis       Date:  2006-02-23       Impact factor: 2.803

3.  Acute brucellosis in Saudi families: relationship between brucella serology and clinical symptoms.

Authors:  Sara Alsubaie; Maha Almuneef; Mohammed Alshaalan; Hanan Balkhy; Essam Albanyan; Sulaiman Alola; Badria Alotaibi; Ziad A Memish
Journal:  Int J Infect Dis       Date:  2005-07       Impact factor: 3.623

4.  Subclinical sacroiliitis in brucellosis. Clinical presentation and MRI findings.

Authors:  T A Gheita; S Sayed; G S Azkalany; H S El Fishawy; M A Aboul-Ezz; M H Shaaban; R H Bassyouni
Journal:  Z Rheumatol       Date:  2015-04       Impact factor: 1.372

5.  Detection and treatment of brucellosis by screening a population at risk.

Authors:  O Abramson; Z Rosenvasser; C Block; R Dagan
Journal:  Pediatr Infect Dis J       Date:  1991-06       Impact factor: 2.129

6.  The many faces of human-to-human transmission of brucellosis: congenital infection and outbreak of nosocomial disease related to an unrecognized clinical case.

Authors:  Oded Mesner; Klaris Riesenberg; Natalia Biliar; Eliezer Borstein; Leah Bouhnik; Nehama Peled; Pablo Yagupsky
Journal:  Clin Infect Dis       Date:  2007-12-15       Impact factor: 9.079

7.  Is family screening necessary in brucellosis?

Authors:  F Tabak; E Hakko; B Mete; R Ozaras; A Mert; R Ozturk
Journal:  Infection       Date:  2008-11-14       Impact factor: 3.553

Review 8.  Human brucellosis.

Authors:  María Pía Franco; Maximilian Mulder; Robert H Gilman; Henk L Smits
Journal:  Lancet Infect Dis       Date:  2007-12       Impact factor: 25.071

9.  Brucellosis seroprevalence in ovine and caprine flocks in China during 2000-2018: a systematic review and meta-analysis.

Authors:  Xuhua Ran; Xiaohong Chen; Miaomiao Wang; Jiajia Cheng; Hongbo Ni; Xiao-Xuan Zhang; Xiaobo Wen
Journal:  BMC Vet Res       Date:  2018-12-12       Impact factor: 2.741

  9 in total
  1 in total

1.  Brucella Seroprevalence and Associated Risk Factors in Occupationally Exposed Humans in Selected Districts of Southern Province, Zambia.

Authors:  Melai Mubanga; Ruth L Mfune; John Kothowa; Ahmed S Mohamud; Chitalu Chanda; John Mcgiven; Flavien N Bumbangi; Bernard M Hang'ombe; Jacques Godfroid; Martin Simuunza; John B Muma
Journal:  Front Public Health       Date:  2021-11-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.